Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|October 24, 2024
Core Concepts in Pharmacoepidemiology: Time-To-Event Analysis Approaches in PharmacoepidemiologyGerd Rippin, Shahrzad Salmasi, Héctor Sanz, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2012
Risk of lymphoma in women with breast implants: analysis of clinical studiesJoan Largent, Michael Oefelein, Hilton M Kaplan, et al.Drug Safety|July 27, 2022
A Review of Causal Inference for External Comparator Arm StudiesGerd Rippin, Nicolás Ballarini, Héctor Sanz, et al.Cancer|December 14, 2004
Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groupsKenneth J Chang, Gulshan Parasher, Catherine Christie, et al.Nutrition and Cancer|October 19, 2006
Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancerArchana Jaiswal McEligot, Joan Largent, Argyrios Ziogas, et al.Plastic and Reconstructive Surgery|August 26, 2011
Anaplastic large T-cell lymphoma and breast implants: a review of the literatureMark Jewell, Scott L Spear, Joan Largent, et al.Frontiers in Drug Safety and Regulation|September 22, 2025
External Comparator Cohort studies - clarification of terminologyGerd Rippin, Joan Largent, Wilhelmina Elisabeth Hoogendoorn, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 14, 2013
Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device typeJames D Namnoum, Joan Largent, Hilton M Kaplan, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Passive smoking and risk of breast cancer in the California teachers studyPeggy Reynolds, Debbie Goldberg, Susan Hurley, et al.Frontiers in Drug Safety and Regulation|September 22, 2025
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studiesChinenye Ugoji, Julien Heidt, Joan Largent, et al.Pageof 3